GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Receivables Turnover

Statera BioPharma (STU:7CB) Receivables Turnover : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Statera BioPharma's Revenue for the three months ended in Sep. 2022 was €0.00 Mil. Statera BioPharma's average Accounts Receivable for the three months ended in Sep. 2022 was €0.20 Mil.


Statera BioPharma Receivables Turnover Historical Data

The historical data trend for Statera BioPharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Receivables Turnover Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Receivables Turnover
- - -

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Statera BioPharma's Receivables Turnover

For the Biotechnology subindustry, Statera BioPharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Statera BioPharma's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Receivables Turnover falls into.



Statera BioPharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Statera BioPharma's Receivables Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Receivables Turnover (A: Dec. 2021 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2021 ) / ((Accounts Receivable (A: Dec. 2020 ) + Accounts Receivable (A: Dec. 2021 )) / count )
=0 / ((0 + 0.191) / 1 )
=0 / 0.191
=N/A

Statera BioPharma's Receivables Turnover for the quarter that ended in Sep. 2022 is calculated as

Receivables Turnover (Q: Sep. 2022 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2022 ) / ((Accounts Receivable (Q: Jun. 2022 ) + Accounts Receivable (Q: Sep. 2022 )) / count )
=0 / ((0.206 + 0.185) / 2 )
=0 / 0.1955
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma  (STU:7CB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Statera BioPharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma Headlines

No Headlines